Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02559401 : Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation
PhaseN/A
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

- brain lesions, including but not limited to tumors, epileptic foci, and vascular
abnormalities, in or around eloquent brain regions (i.e., motor, language);

- clinical need for pre-operative 'advanced imaging' (which includes conventional DTI);

- age between 18-80 years of age;

- male or female gender. Eloquent regions include: Temporal and frontal lobes
(speech/language); bilateral occipital lobes (vision); bilateral parietal lobes
(sensation); and bilateral motor cortex (movement).

Exclusion Criteria:

- a contraindication for obtaining an MRI scan (e.g. implanted devices, retrained
foreign body)

- pregnancy

- absence of the capacity to make medical decisions or provide informed consent.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02559401      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740